JP2010502582A5 - - Google Patents

Download PDF

Info

Publication number
JP2010502582A5
JP2010502582A5 JP2009526177A JP2009526177A JP2010502582A5 JP 2010502582 A5 JP2010502582 A5 JP 2010502582A5 JP 2009526177 A JP2009526177 A JP 2009526177A JP 2009526177 A JP2009526177 A JP 2009526177A JP 2010502582 A5 JP2010502582 A5 JP 2010502582A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
aryl
alkynyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009526177A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010502582A (ja
JP5506386B2 (ja
Filing date
Publication date
Priority claimed from GB0617278A external-priority patent/GB0617278D0/en
Priority claimed from GB0625929A external-priority patent/GB0625929D0/en
Application filed filed Critical
Priority claimed from PCT/GB2007/003302 external-priority patent/WO2008029096A2/en
Publication of JP2010502582A publication Critical patent/JP2010502582A/ja
Publication of JP2010502582A5 publication Critical patent/JP2010502582A5/ja
Application granted granted Critical
Publication of JP5506386B2 publication Critical patent/JP5506386B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009526177A 2006-09-04 2007-09-04 Ｐ５３活性化化合物 Expired - Fee Related JP5506386B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0617278A GB0617278D0 (en) 2006-09-04 2006-09-04 P53 activating compounds
GB0617278.7 2006-09-04
GB0625929.5 2006-11-23
GB0625929A GB0625929D0 (en) 2006-12-23 2006-12-23 P53 activating compounds
PCT/GB2007/003302 WO2008029096A2 (en) 2006-09-04 2007-09-04 P53 activating benzoyl urea and benzoyl thiourea compounds

Publications (3)

Publication Number Publication Date
JP2010502582A JP2010502582A (ja) 2010-01-28
JP2010502582A5 true JP2010502582A5 (enExample) 2010-10-21
JP5506386B2 JP5506386B2 (ja) 2014-05-28

Family

ID=38819391

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009526177A Expired - Fee Related JP5506386B2 (ja) 2006-09-04 2007-09-04 Ｐ５３活性化化合物

Country Status (6)

Country Link
US (2) US8501991B2 (enExample)
EP (1) EP2099445B1 (enExample)
JP (1) JP5506386B2 (enExample)
AT (1) ATE488232T1 (enExample)
DE (1) DE602007010664D1 (enExample)
WO (1) WO2008029096A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2118123B1 (en) 2007-01-31 2015-10-14 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
US8580488B2 (en) * 2007-02-05 2013-11-12 City Of Hope Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance
US8952028B2 (en) 2007-02-05 2015-02-10 City Of Hope Methods of treating chemoresistance and relapse in cancer cells
EP3159352B1 (en) 2007-03-28 2023-08-02 President and Fellows of Harvard College Stitched polypeptides
US20100137345A1 (en) * 2007-05-14 2010-06-03 Universite Libre De Bruxelles Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
FR2930552B1 (fr) * 2008-04-24 2012-10-12 Centre Nat Rech Scient N-acylthiourees et n-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog
US20120136033A1 (en) * 2009-05-18 2012-05-31 President And Fellows Of Harvard College Small Molecule Antagonists of Phosphatidylinositol-3,4,5-Triphosphate (PIP3) and Uses Thereof
GB0909912D0 (en) 2009-06-09 2009-07-22 Univ Dundee Compounds
EP2865668A3 (en) * 2010-02-19 2015-09-23 Siga Technologies, Inc. Inhibitors and methods of inhibiting bacterial and viral pathogens
KR102104762B1 (ko) 2010-08-13 2020-04-24 에일러론 테라퓨틱스 인코포레이티드 펩티도미메틱 거대고리
US10016414B2 (en) 2010-11-12 2018-07-10 University Of Massachusetts Modulation of ubiquitination of synaptic proteins for the treatment of neurodegenerative and psychiatric disorders
FR2980477B1 (fr) * 2011-09-23 2013-10-18 Centre Nat Rech Scient Nouveaux composes modulateurs de la voie de signalisation des proteines hedgehog, leurs formes marquees, et applications
TW201806968A (zh) 2011-10-18 2018-03-01 艾利倫治療公司 擬肽巨環化合物
NZ627528A (en) 2012-02-15 2016-05-27 Aileron Therapeutics Inc Peptidomimetic macrocycles
CA2864120A1 (en) 2012-02-15 2013-08-22 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
BR112015009470A2 (pt) 2012-11-01 2019-12-17 Aileron Therapeutics Inc aminoácidos dissubstituídos e seus métodos de preparação e uso
WO2014186313A1 (en) * 2013-05-13 2014-11-20 Glaxosmithkline Llc Substituted bridged urea analogs as sirtuin modulators
MX389354B (es) 2014-09-24 2025-03-20 Aileron Therapeutics Inc Macrociclos peptidomimeticos y formulaciones de los mismos.
KR20170058424A (ko) 2014-09-24 2017-05-26 에일러론 테라퓨틱스 인코포레이티드 펩티드모방 거대고리 및 이의 용도
SG11201707750YA (en) 2015-03-20 2017-10-30 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
US10023613B2 (en) 2015-09-10 2018-07-17 Aileron Therapeutics, Inc. Peptidomimetic macrocycles as modulators of MCL-1
CN115724780B (zh) * 2022-11-17 2024-04-26 武汉大学 一种基于疏水标签的酰基硫脲类化合物及其制备方法与抗甲型流感病毒的应用
CN117069631A (zh) * 2023-08-15 2023-11-17 北京中医药大学 一种具有抗肿瘤活性的新型硫脲类化合物及其制备方法与应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0117320B1 (en) 1983-01-24 1987-03-04 Duphar International Research B.V Benzoylurea compounds, and pesticidal compositions comprising same
EP0116728B1 (en) 1983-01-24 1987-08-12 Duphar International Research B.V Composition active against mites, whitefly and thrips, pharmaceutical composition, and new benzoylureau compounds
DE3478573D1 (en) * 1983-09-01 1989-07-13 Duphar Int Res Benzoyl urea derivatives having anti-tumor activity
AU601145B2 (en) * 1985-03-01 1990-09-06 Duphar International Research B.V. Benzoyl urea derivatives having anti-tumor activity
AU642524B2 (en) 1990-09-10 1993-10-21 Duphar International Research B.V. Pharmaceutical formulation containing a benzoyl urea derivative
JPH05247001A (ja) * 1991-12-05 1993-09-24 Ishihara Sangyo Kaisha Ltd 置換ベンゾイルウレア誘導体又はその塩、それらの製造方法及びそれらを含有する抗癌剤
KR950026862A (ko) 1994-03-15 1995-10-16 강박광 벤조일 우레아 유도체
JPH07285952A (ja) * 1994-04-08 1995-10-31 Fujisawa Pharmaceut Co Ltd 新規複素環誘導体
US20060004085A1 (en) * 2002-03-29 2006-01-05 University Of Maryland , Baltimore Inhibitors of the S100-p53 protein-protein interaction and method of inhibiting cancer employing the same
EP1539724B1 (en) 2002-08-07 2007-10-10 Neuraxon Inc. Amino benzothiazole compounds with nos inhibitory activity
US7087761B2 (en) * 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
TW200600492A (en) 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
US20080207760A1 (en) 2005-04-11 2008-08-28 Achillion Pharmaceuticals, Inc. Pharmaceutical Compositions For and Methods of Inhibiting Hcv

Similar Documents

Publication Publication Date Title
JP2010502582A5 (enExample)
BRPI0516284A (pt) anticorpo construìdo com cisteìna, método de selecionar anticorpos, compostos conjugados de droga-anticorpo, composição farmacêutica, método para matar ou inibir a proliferação de células de tumor, métodos de inibir a proliferação celular e o crescimento de células de tumor, artigo manufaturado e método para produzir um composto
AU2011329829B2 (en) Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
WO2016049069A1 (en) Methods of treating liver disease
KR20150013527A (ko) 항염증 활성과 접합된 증진된 항인플루엔자제
JP2009537461A5 (enExample)
US11987647B2 (en) Cyclic cell-penetrating peptides with one or more hydrophobic residues
KR20200015528A (ko) 전신 인슐린 내성 질환의 치료용 화합물 및 그의 용도
Sharma et al. Discovery of a membrane-active, ring-modified histidine containing ultrashort amphiphilic peptide that exhibits potent inhibition of Cryptococcus neoformans
JP2016522831A (ja) 炎症を予防および治療するためのクリオピリン阻害剤
EP3534910A2 (en) Therapeutic agents and methods
KR20200035982A (ko) 의학적 장애의 예방 및 치료를 위한 화합물 및 이의 용도
JP7777263B2 (ja) ステロイド受容体コアクチベーター－３の小分子刺激因子ならびに心臓保護剤及び／または血管再生剤としてのそれらの使用方法
EP3870231A1 (en) Biomarkers of metap2 inhibitors and applications thereof
RU2020108281A (ru) Новые ацилированные аналоги инсулина и варианты их применения
EP4294820A1 (en) Cyclic cell-penetrating peptides with three or more hydrophobic residues
US20180311367A1 (en) Multivalent peptoid oligomers, pharmaceutical compositions and methods of using same
US11702443B2 (en) Therapeutic agents and methods
US10787413B2 (en) Derivatives of curcuminoids and use thereof as an anticancer agent
CN104546819A (zh) 二咖啡酰奎宁酸在治疗系统性自身免疫性疾病中的用途
US10450295B2 (en) Method of using an indolinone molecule and derivatives for inhibiting liver fibrosis and hepatitis
TW201010988A (en) 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
KR20170038869A (ko) 경쟁적 ppar-감마 길항제
CN103965193A (zh) N-(苯氧烷基)咪唑并[1,2-a]吡啶-3-酰胺类化合物及其制备方法
JP2004536109A5 (enExample)